Interactions
361 - 375 of
611 Results
Sort Results:
Article:
a stronger push to offer drug therapy for primary prevention of breast cancer in higher-risk women
September 2013
Article:
Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes
August 2013
Article:
Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge
July 2013